Larimar Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.05

-0.15 (-4.69%)

As of Jun 30, 10:19 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +663.0% upside

Low Target $16.60

Average Target $23.27

High Target $30.48

Current Price $3.05

Current
$3.05

Target
$23.27

$16.60 $23.27 avg $30.48

Scenario Analysis

Bear Case

$16.60

444.3%

Low target

Base Case

$23.27

+663.0%

Avg target

Bull Case

$30.48

+899.3%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$6.42

-52.5% from high

52-Week Low

$2.72

+12.3% from low

Target vs 52W High

$23.27

+262.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%